Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD)
Phase 3
Completed
- Conditions
- Generalized Anxiety Disorder (GAD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-12-03
- Last Posted Date
- 2018-09-26
- Lead Sponsor
- Edgemont Pharmaceuticals, LLC
- Target Recruit Count
- 495
- Registration Number
- NCT02305797
- Locations
- 🇺🇸
Multiple Investigational Sites, Multiple Locations, California, United States
News
No news found